India's First Indigenous Hepatitis A Vaccine: Havisure
Jan 19, 2024 17:18
Indian Immunologicals launches Havisure, India's first indigenously developed Hepatitis A vaccine, offering protection against the viral infection.
New Delhi, Jan 19 (PTI) Indian Immunologicals on Friday said it has launched the country's first indigenously developed Hepatitis A vaccine.
The vaccine -- Havisure -- represents a significant step forward in the country's fight against Hepatitis A, the company, which is a wholly-owned subsidiary of the National Dairy Development Board (NDDB), said in a statement.
Hepatitis A is a viral infection primarily spread through the fecal-oral route, meaning that it is transmitted through the ingestion of contaminated food or water.
"Currently Hepatitis A vaccines are imported into the country...Havisure has undergone extensive clinical trials in eight centres and has proven to be safe and efficacious," Indian Immunologicals Ltd (IIL) Managing Director K Anand Kumar said.
The vaccine is comparable to the world's leading vaccine sold by multinational companies, he added.
Havisure is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.